UBS Navigates Legal Minefield as Shareholder Payouts Loom

UBS faces US legal pressure over Nazi-era documents while proposing dividends and buybacks. New Swiss capital rules could require up to $22B as one major legacy case is dismissed.

As UBS prepares to welcome shareholders to its annual meeting next week, the Swiss banking giant finds itself balancing substantial capital returns against a backdrop of escalating legal tensions. The bank’s refusal to hand over privileged documents to a US investigator probing historical Nazi-era accounts has sparked a confrontation that threatens to spill into congressional hearings, casting a shadow over its otherwise steady operational progress.

This legal blockade centers on sensitive materials from 1990s settlement proceedings related to the inherited Credit Suisse business. UBS has stated that insufficient protections against new financial claims prevent their release, drawing criticism from a US Senate subcommittee for a lack of cooperation. If the dispute escalates, public hearings in Washington could loom by autumn 2026, potentially complicating the bank's valuable US operations.

A Major Legal Burden Lifted, Another Intensifies

The fresh US scrutiny arrives just as UBS finally shed one of its most prominent legal legacies. A Swiss federal court in Bellinzona recently dismissed criminal proceedings tied to the Mozambique scandal, citing a procedural obstacle. The court ruled that with Credit Suisse's dissolution as a legal entity, the subject of the prosecution had vanished and refused to transfer liability to UBS as its successor. This closes a chapter on a saga dating to 2013, involving over $2 billion in loans to Mozambican state firms.

Investor focus now shifts to the upcoming General Meeting in Basel on April 15. The agenda includes a proposed dividend of USD 1.10 per share for the 2025 financial year and planned share buybacks of approximately USD 3 billion for 2026. Shareholders are expected to press management for clarity on potential provisions for other Credit Suisse-era liabilities, even as the bank proceeds with generous capital distribution.

Regulatory and Capital Hurdles on the Horizon

Beyond courtrooms, UBS faces significant regulatory challenges. Proposed Swiss "Too Big To Fail" reforms could force the bank to fully back foreign subsidiaries with hard equity capital. UBS itself estimates this could create an additional capital requirement of up to USD 22 billion. The Swiss parliament is set to debate draft legislation from May, with potential to soften the final requirements.

Deutsche Bank Research maintains a Buy rating on UBS with a price target of CHF 39. Analyst Benjamin Goy anticipates greater regulatory clarity on these reforms in April. The shares currently trade at EUR 35.63, roughly 35% above their 52-week low. Operationally, the bank is scheduled to report Q1 2026 results on April 29, with analysts expecting solid net new money inflows, particularly from Asia-Pacific and EMEA regions.

The coming weeks present a critical juncture for UBS. The annual meeting will serve as a barometer of investor confidence as the bank juggles its attractive shareholder remuneration policy against unresolved legal risks and a looming regulatory overhaul. Its long-term target of an 18% return on tangible equity by 2028 remains in sight, but the path is increasingly lined with both old and new obstacles.